Workboat Indexes

Vanda Pharmaceuticals Inc. - Common Stock (NQ: VNDA )

4.780 +0.150 (+3.24%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist

Price and Volume

Volume	926,409
Open	4.590
Bid (Size)	4.590 (2)
Ask (Size)	4.900 (15)
Prev. Close	4.630
Today's Range	4.590 - 4.830
52wk Range	3.460 - 6.750
Shares Outstanding	55,638,166
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Glancy Prongay & Murray LLP Announces Investigation of Vanda Pharmaceuticals Inc.

December 16, 2024

From Glancy Prongay & Murray LLP

Via Business Wire

Over 200% Stock Upside - Vanda Pharmaceuticals Undervalued With Robust Portfolio And Pipeline: Analyst

November 01, 2024

HC Wainwright initiates Buy on Vanda Pharmaceuticals with an $18 price target, citing undervaluation, a strong product portfolio, and growth in neurology.

Via Benzinga

Performance

YTD	+5.75%	+5.75%
1 Month	-3.24%	-3.24%
3 Month	+0.63%	+0.63%
6 Month	-20.07%	-20.07%
1 Year	+20.40%	+20.40%

More News

Why Vanda Pharmaceuticals Stock Sank by Nearly 6% Today

September 19, 2024

Via The Motley Fool

FDA Strikes Off Vanda Pharmaceuticals' Tradipitant For Stomach Paralysis, Asks For Additional Studies

September 19, 2024

Via Benzinga

Revolutionary Magnetic Therapy Could Speed Up Bipolar Treatment

August 06, 2024

Via PressReach

Why Vanda Pharmaceuticals Stock Is Skyrocketing Today

April 17, 2024

Via The Motley Fool

What's Going On With Vanda Pharmaceuticals Shares Today?

June 27, 2024

Via Benzinga

Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

June 20, 2024

Via Benzinga

Why Vuzix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

June 20, 2024

Via Benzinga

Vanda Pharmaceuticals And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

June 20, 2024

Via Benzinga

Tesla, Nvidia, John Wiley & Sons And Other Big Stocks Moving Higher On Thursday

June 13, 2024

Via Benzinga

Glancy Prongay & Murray LLP Announces Investigation of Vanda Pharmaceuticals Inc.

June 10, 2024

From Glancy Prongay & Murray LLP

Via Business Wire

S&P 500 Edges Lower; J. M. Smucker Shares Surge Following Earnings Beat

June 06, 2024

Via Benzinga

Why G-III Apparel Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

June 06, 2024

Via Benzinga

Crude Oil Jumps 2%; Lululemon Posts Upbeat Earnings

June 06, 2024

Via Benzinga

Vanda Pharmaceuticals Receives Another Takeover Proposal, Considers $466M Deal

June 06, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

June 06, 2024

Via InvestorPlace

Exact Sciences Reports Q1 Loss, Joins Beyond Meat, Duolingo And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

May 09, 2024

Via Benzinga

VNDA Stock Earnings: Vanda Pharma Misses EPS, Misses Revenue for Q1 2024

May 08, 2024

Via InvestorPlace

Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda Pharmaceuticals

April 25, 2024

From Shareholder Capital LLC

Via GlobeNewswire

US Supreme Court Declines To Hear Vanda Pharmaceuticals' Case Regarding Invalidation Of Patents For Its Sleep Disorder Drug, Hetlioz

April 22, 2024

Via Benzinga

Crude Oil Dips 3%; U.S. Bancorp Profit Tops Views

April 17, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session

April 17, 2024

Via Benzinga

Neuropsychiatric-Focused Vanda Pharmaceuticals Rejects Future Pak's Takeover Bid Valued Up To $7.75/Share

April 17, 2024

Via Benzinga

Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

April 17, 2024

Via Benzinga

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.